- R&D
Boston Scientific’s Farapulse System Irregular Heartbeat Treatment
Boston Scientific, a pioneering force in medical technology, has revealed clinical data from a head-to-head trial that underscores the immense potential of...Two-Year Study Shows Nevro’s High-Frequency Neurostimulation Reduces Diabetic Neuropathy Pain by 80%
Nevro's high-frequency neurostimulation system, after being granted FDA approval as the pioneering spinal cord stimulator to alleviate diabetic neuropathy pain, has received...Takeda Pulls Application For Dengue Vaccine Qdenga
Travelers and medical professionals from the U.S. who are hoping for a different, maybe safer, dengue vaccination will have to wait.Novartis drug helps stop breast cancer’s return in a large study
According to clinical study findings, when administered following surgery in adults at risk of recurrence, a Novartis-targeted medicine lowered the chance of...
- Clinical
With the trial’s success, AbbVie prepares Botox for a different aesthetic use
Recently, AbbVie disclosed positive outcomes from a second phase 3 trial of Botox, aimed at managing moderate to severe platysma prominence. This...Blackstone’s $250 million investment in ex-Novartis assets pays off
Blackstone Life Sciences' substantial $250 million investment in Anthos Therapeutics' abelacimab, formerly known as MAA868 has yielded promising results. Novartis initially introduced...Arbutus Halts COVID-19 RNA Destabilization Projects After Reviewing Early Preclinical Data
Arbutus Biopharma has undertaken a substantial shift in its strategic direction, opting to withdraw from its involvement in COVID-19 research and discontinue...Novocure’s TTFields Misses the Mark in Phase 3 Ovarian Cancer Trial
In a striking departure from earlier this year's promising findings, Novocure's groundbreaking technology known as Tumor Treating Fields (TTFields) has encountered a...
- Manufacturing
Merck and Ginkgo Forge $490 Million Partnership to Enhance Biologics Manufacturing Efficiency
Merck has solidified a substantial collaboration valued at $490 million with Ginkgo Bioworks, aimed at revolutionizing the landscape of biologics manufacturing. This...Vertex and Lonza Join Forces to Open New Manufacturing Facility for the Former’s T1D Therapies
Vertex Pharmaceuticals and Lonza have announced a strategic partnership to construct a new joint manufacturing facility in Portsmouth, New Hampshire. The primary...Pfizer to Stop Development of Oral Obesity Drug Amidst Liver Safety Concerns
Pfizer is set to discontinue one of its oral obesity drugs - namely lotiglipron - after observing higher levels of liver enzymes...Novartis Secures $3.2 Billion Acquisition of Chinook to Enhance Kidney Disease Strategy
Novartis, the Swiss pharmaceutical giant, is set to bolster its kidney disease pipeline through the acquisition of Chinook Therapeutics for an impressive...
- Commercial
CGM-connected app feature for Type 2 diabetes patients, unveiled by Abbott and WeightWatchers
One year after allying with the shared objective of enhancing health management for individuals diagnosed with Type 2 diabetes, Abbott and WeightWatchers...Fresh Tracks Set to Dissolve with no Buyer in the Pipeline
After months of looking into various other possibilities, Fresh Tracks Therapeutics has decided to dissolve its operations, as the board of directors...Sanofi divests 11 CNS medications to Pharmanovia in a strategic slimming-down move
In a strategic maneuver aimed at streamlining its product portfolio, pharmaceutical juggernaut Sanofi has initiated the sale of 11 central nervous system...
- Technology
Trialbee’s new tool aims to expedite clinical trial recruitment delays
Clinical trials play a pivotal role in advancing medical research and the development of innovative treatments. However, one major hurdle that often...Revvity introduces advanced preclinical imaging tech for scientists to make breakthroughs
Revvity, Inc. is ushering in a new era of innovation in the realm of preclinical research by introducing an advanced imaging portfolio...GE HealthCare introduces Vscan Air SL: a handheld ultrasound device for rapid cardiovascular assessment
GE Healthcare has unveiled its latest innovation: the Vscan Air SL handheld ultrasound device. This pioneering addition to the Vscan line promises...Living fillings: the future of regenerative dentistry?
While dental technology has advanced significantly over the years, the ability to regrow lost teeth has remained elusive. However, a groundbreaking study...
- Regulatory
FDA Gives Green Light to GSK’s Innovative Bone Cancer Drug, Validating Billion-Dollar Investment
The Food and Drug Administration (FDA) has granted approval for GSK's groundbreaking treatment for myelofibrosis, a form of bone marrow cancer, signifying...FDA Issues Warning to 8 Companies Selling Illegal Eye Drugs
The Food and Drug Administration (FDA) said on Tuesday that it is taking action against eight different firms because it believes they...Scientists successfully grow part-human part-pig kidneys to solve transplant crisis
Researchers have successfully cultivated part-human, part-pig kidneys within pig embryos, ushering in a new era of organ transplantation possibilities.Ahead of the seasonal spike, Pfizer and BioNTech’s Covid vaccine receives FDA greenlight
The U.S. FDA has taken a significant step by approving modified mRNA vaccines for COVID-19 from Pfizer-BioNTech and Moderna while discontinuing the...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
- R&D
Boston Scientific’s Farapulse System Irregular Heartbeat Treatment
Boston Scientific, a pioneering force in medical technology, has revealed clinical data from a head-to-head trial that underscores the immense potential of...Two-Year Study Shows Nevro’s High-Frequency Neurostimulation Reduces Diabetic Neuropathy Pain by 80%
Nevro's high-frequency neurostimulation system, after being granted FDA approval as the pioneering spinal cord stimulator to alleviate diabetic neuropathy pain, has received...Takeda Pulls Application For Dengue Vaccine Qdenga
Travelers and medical professionals from the U.S. who are hoping for a different, maybe safer, dengue vaccination will have to wait.Novartis drug helps stop breast cancer’s return in a large study
According to clinical study findings, when administered following surgery in adults at risk of recurrence, a Novartis-targeted medicine lowered the chance of...
- Clinical
With the trial’s success, AbbVie prepares Botox for a different aesthetic use
Recently, AbbVie disclosed positive outcomes from a second phase 3 trial of Botox, aimed at managing moderate to severe platysma prominence. This...Blackstone’s $250 million investment in ex-Novartis assets pays off
Blackstone Life Sciences' substantial $250 million investment in Anthos Therapeutics' abelacimab, formerly known as MAA868 has yielded promising results. Novartis initially introduced...Arbutus Halts COVID-19 RNA Destabilization Projects After Reviewing Early Preclinical Data
Arbutus Biopharma has undertaken a substantial shift in its strategic direction, opting to withdraw from its involvement in COVID-19 research and discontinue...Novocure’s TTFields Misses the Mark in Phase 3 Ovarian Cancer Trial
In a striking departure from earlier this year's promising findings, Novocure's groundbreaking technology known as Tumor Treating Fields (TTFields) has encountered a...
- Manufacturing
Merck and Ginkgo Forge $490 Million Partnership to Enhance Biologics Manufacturing Efficiency
Merck has solidified a substantial collaboration valued at $490 million with Ginkgo Bioworks, aimed at revolutionizing the landscape of biologics manufacturing. This...Vertex and Lonza Join Forces to Open New Manufacturing Facility for the Former’s T1D Therapies
Vertex Pharmaceuticals and Lonza have announced a strategic partnership to construct a new joint manufacturing facility in Portsmouth, New Hampshire. The primary...Pfizer to Stop Development of Oral Obesity Drug Amidst Liver Safety Concerns
Pfizer is set to discontinue one of its oral obesity drugs - namely lotiglipron - after observing higher levels of liver enzymes...Novartis Secures $3.2 Billion Acquisition of Chinook to Enhance Kidney Disease Strategy
Novartis, the Swiss pharmaceutical giant, is set to bolster its kidney disease pipeline through the acquisition of Chinook Therapeutics for an impressive...
- Commercial
CGM-connected app feature for Type 2 diabetes patients, unveiled by Abbott and WeightWatchers
One year after allying with the shared objective of enhancing health management for individuals diagnosed with Type 2 diabetes, Abbott and WeightWatchers...Fresh Tracks Set to Dissolve with no Buyer in the Pipeline
After months of looking into various other possibilities, Fresh Tracks Therapeutics has decided to dissolve its operations, as the board of directors...Sanofi divests 11 CNS medications to Pharmanovia in a strategic slimming-down move
In a strategic maneuver aimed at streamlining its product portfolio, pharmaceutical juggernaut Sanofi has initiated the sale of 11 central nervous system...
- Technology
Trialbee’s new tool aims to expedite clinical trial recruitment delays
Clinical trials play a pivotal role in advancing medical research and the development of innovative treatments. However, one major hurdle that often...Revvity introduces advanced preclinical imaging tech for scientists to make breakthroughs
Revvity, Inc. is ushering in a new era of innovation in the realm of preclinical research by introducing an advanced imaging portfolio...GE HealthCare introduces Vscan Air SL: a handheld ultrasound device for rapid cardiovascular assessment
GE Healthcare has unveiled its latest innovation: the Vscan Air SL handheld ultrasound device. This pioneering addition to the Vscan line promises...Living fillings: the future of regenerative dentistry?
While dental technology has advanced significantly over the years, the ability to regrow lost teeth has remained elusive. However, a groundbreaking study...
- Regulatory
FDA Gives Green Light to GSK’s Innovative Bone Cancer Drug, Validating Billion-Dollar Investment
The Food and Drug Administration (FDA) has granted approval for GSK's groundbreaking treatment for myelofibrosis, a form of bone marrow cancer, signifying...FDA Issues Warning to 8 Companies Selling Illegal Eye Drugs
The Food and Drug Administration (FDA) said on Tuesday that it is taking action against eight different firms because it believes they...Scientists successfully grow part-human part-pig kidneys to solve transplant crisis
Researchers have successfully cultivated part-human, part-pig kidneys within pig embryos, ushering in a new era of organ transplantation possibilities.Ahead of the seasonal spike, Pfizer and BioNTech’s Covid vaccine receives FDA greenlight
The U.S. FDA has taken a significant step by approving modified mRNA vaccines for COVID-19 from Pfizer-BioNTech and Moderna while discontinuing the...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
Editor Picks
Is Biogen’s Alzheimer’s drug worth $56K? Experts say $8400 and raise questions about efficacy
Aduhelm, Biogen’s new drug for Alzheimer’s disease, which was approved by FDA contentiously last month, continues to face criticism since then.
Revolo Reveals Positive Midphase Data For EoE Candidate
Revolo Biotherapeutics believes that it possesses the data necessary to continue developing...
Life Sciences Voice Top Five Newsletter
This week we take a look at a possible treatment for HIV,...
Must Read
CGM-connected app feature for Type 2 diabetes patients, unveiled by Abbott and WeightWatchers
One year after allying with the shared objective of enhancing health management...
With the trial’s success, AbbVie prepares Botox for a different aesthetic use
Recently, AbbVie disclosed positive outcomes from a second phase 3 trial of...
Fresh Tracks Set to Dissolve with no Buyer in the Pipeline
After months of looking into various other possibilities, Fresh Tracks Therapeutics has...
About Us
Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.
Contact us: reachout(at)lifescivoice.com